Skip to content

PHARMA 2424

Active Private limited companyfounded 2011active for 14 yearsRue Neuve 1, 6061 CharleroiKBO/BCE: BE 0842.084.219 #8 oldest company in Hainaut, Pharmaceuticals sector

Lifetime

14 annual accounts with figures on one time axis
peak of €226,462 in 2021
€195,539▼ 0.7%
lowest -€22,717 in 2012
€56,862▲ 3.0%
peak of €304,601 in 2025
€304,601▲ 23.0%
€245,804▼ 31.9%
peak of 1.4 FTE in 2024
1.1 FTE▼ 21.4%
Board4 names since 2011
4 directors and 3 others
Documentsfilings and deeds
07-08-20267 days late
2025abbreviated format
Staff from 1.4 FTE to 1.1 FTEEquity from €247,740 to €304,601Debts from €360,802 to €245,804Cash from €139,824 to €70,643

Key points

from the 2025 annual accounts

Equity

€304,601 ▲ 23.0%

PHARMA 2424 has made a profit without a break since 2019.

Staff

3 employees on 31-12-2025
332024642025

In 2025, 6 employees joined and 4 left.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 100 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as PHARMA 2424 has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for PHARMA 2424. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-12-2011
Manager, since 23-12-2011
Director, since 23-12-2011
Manager, since 23-12-2011
  • 375 sharesdeed of 22-01-2018
  • 375 sharesdeed of 22-01-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0842084219
(director) and (director) change roles Discharge granted to (manager) · Discharge granted to (manager) · General meeting of 02-10-2023 · Gazette deed
Company renamed from PHARMAROME to PHARMA 2424 Registered office moved within Montignies-sur-Sambre · Capital increase of €75,000 to €93,600 · The capital rose from €18,600 to €93,600, with 750 new shares · General meeting of 27-12-2017 · Gazette deed
New establishment in Charleroi Rue Neuve 1
All 27 events

Comparable companies

same main activity, similar in size and age
Company
PHARMA 2424 Charleroi €0.6m €195,539 55.3% 1.1
Brussels Medical Center Oostkamp €0.3m €237,889 5.8% 4.3
BLRCE Lessines €1.6m €236,672 16.5% 3.2
CEREPHARMA Ath €1.5m €572,300 61.2% 6.3
EXEL DENTAL Braine-le-Comte €0.4m €145,877 24.4% -
MICROBELCAPS Liège €0.8m €354,668 69.5% 4.4
DCVISION Kaprijke €0.4m €158,650 47.6% -

These companies have the same main activity as PHARMA 2424: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €272,000 and €1.6m, founded between 1995 and 2019.

Official details

Source: KBO
Status
Active since 23-12-2011Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 1 other
Establishment units
2.205.898.1806061 Charleroi, since 23-12-2011
2.271.844.9186061 Charleroi, since 01-01-2018
Financial year end
31 December
Peppol
Reachable since 11-12-2025
Company details

Annual accounts 2025

≈ €500,000estimated
€550,405▼ 9.6%
Employeeson 31-12-2025
3▲ 200%
Filing
Filed on 07-08-2026
Financials

Insights on PHARMA 2424

PHARMA 2424 files the abbreviated format. That format states no turnover. The gross margin rose from -€14,100 in 2012 to €195,539 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMA 2424

What is the company number of PHARMA 2424?
The company number of PHARMA 2424 is 0842.084.219. The VAT number is the same number with BE in front: BE 0842.084.219.
Where is PHARMA 2424 based?
The registered office is at Rue Neuve 1, 6061 Charleroi.Company details
What does PHARMA 2424 do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
What is the legal form of PHARMA 2424?
PHARMA 2424 is a private limited company (BV).
When was PHARMA 2424 founded?
PHARMA 2424 was founded on 23-12-2011.
Is PHARMA 2424 still active?
Yes, PHARMA 2424 is an active enterprise in the KBO register.
How many employees does PHARMA 2424 have?
PHARMA 2424 had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMA 2424?
The turnover in financial year 2025 is about €500,000. This figure is estimated from the gross margin of €195,539 and 1,394 comparable companies of the same size. It probably lies between €300,000 and €950,000. It is a rough estimate.
Is PHARMA 2424 profitable?
In financial year 2025, PHARMA 2424 made a profit of €56,862.
Where can I find the annual accounts of PHARMA 2424?
PHARMA 2424 filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMA 2424 due?
PHARMA 2424 must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.